DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo


2.74 0.16 (6.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VVUS $2.74 6.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.73
Previous Close $2.58
Daily Range $2.63 - $2.86
52-Week Range $2.56 - $8.44
Market Cap $284.1M
P/E Ratio -3.63
Dividend (Yield) $0.00 (0.0%)
Volume 3,855,218
Average Daily Volume 2,456,862
Current FY EPS -$0.76





VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website:

News & Commentary

Forget Pills! Could This Device Put an End to Obesity in America?

We've witnessed three oral anti-obesity meds approved since mid-2012, but this newly approved device could be a game-changer.

Arena's Belviq Prescriptions Fall: More Publicity Is Needed

Novo Nordisk Receives Positive Opinion In Europe On Obesity Treatment

Benzinga's Top #PreMarket Gainers

Arena Pharmaceuticals to Raise Fund Via Share Issuance - Analyst Blog

The 52-Week Low Club for Thursday

Vivus (VVUS) Weak On High Volume

5 Obesity Stocks Investors Are Watching

Vivus Gets New 10% Stakeholder: What To Watch For

Orexigen's Contrave May Have Pricing Competition

See More VVUS News...

VVUS's Top Competitors

VVUS $2.74 (6.20%)
Current stock: VVUS
JNJ $102.20 (-1.50%)
Current stock: JNJ
NVS $96.87 (0.03%)
Current stock: NVS
RHHBY $35.35 (1.83%)
Current stock: RHHBY